Answers are grounded in this paper and cite their sources.
Approval reports the efficacy of ferric maltol for treating iron deficiency in pediatric patients, indicating safer dosing.
Ferric maltol (Accrufer) has been approved to treat pediatric patients ages 10 years and older. It was previously approved for adults. Nurses should teach patients and their families the correct way to administer the drug and about its potential adverse effects.
No takes yet. Share an insight, caveat, or question.
Diane S. Aschenbrenner (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: